Literature DB >> 34643001

A Regioselectively Oxidized 2D Bi/BiOx Lateral Nano-Heterostructure for Hypoxic Photodynamic Therapy.

Meng Qiu1,2, Dou Wang3, Hao Huang1, Teng Yin1, Wenli Bao1, Bin Zhang1, Zhongjian Xie1, Ni Xie1, Zongze Wu3, Chenchen Ge3, Qi Wang4, Meng Gu4, Hilliard L Kutscher5,6,7, Liping Liu3, Shiyun Bao3, Paras N Prasad5, Han Zhang1.   

Abstract

Optoelectronic science and 2D nanomaterial technologies are currently at the forefront of multidisciplinary research and have numerous applications in electronics and photonics. The unique energy and optically induced interfacial electron transfer in these nanomaterials, enabled by their relative band alignment characteristics, can provide important therapeutic modalities for healthcare. Given that nano-heterostructures can facilitate photoinduced electron-hole separation and enhance generation of reactive oxygen species (ROS), 2D nano-heterostructure-based photosensitizers can provide a major advancement in photodynamic therapy (PDT), to overcome the current limitations in hypoxic tumor microenvironments. Herein, a bismuthene/bismuth oxide (Bi/BiOx)-based lateral nano-heterostructure synthesized using a regioselective oxidation process is introduced, which, upon irradiation at 660 nm, effectively generates 1 O2 under normoxia but produces cytotoxic •OH and H2 under hypoxia, which synergistically enhances PDT. Furthermore, this Bi/BiOx nano-heterostructure is biocompatible and biodegradable, and, with the surface molecular engineering used here, it improves tumor tissue penetration and increases cellular uptake during in vitro and in vivo experiments, yielding excellent oxygen-independent tumor ablation with 660 nm irradiation, when compared with traditional PDT agents.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  2D materials; bismuthene; hypoxia; lateral nano-heterostructures; photodynamic therapy

Mesh:

Substances:

Year:  2021        PMID: 34643001     DOI: 10.1002/adma.202102562

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   30.849


  5 in total

Review 1.  Progress of Nanomaterials in Photodynamic Therapy Against Tumor.

Authors:  Lei Chen; Jiahui Huang; Xiaotong Li; Miaoting Huang; Shaoting Zeng; Jiayi Zheng; Shuyi Peng; Shiying Li
Journal:  Front Bioeng Biotechnol       Date:  2022-05-31

Review 2.  Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years.

Authors:  Xinyan Hao; Junyong Wu; DaXiong Xiang; Yongyu Yang
Journal:  Front Pharmacol       Date:  2022-02-18       Impact factor: 5.810

3.  Tumor Biochemical Heterogeneity and Cancer Radiochemotherapy: Network Breakdown Zone-Model.

Authors:  Argyris Dimou; Panos Argyrakis; Raoul Kopelman
Journal:  Entropy (Basel)       Date:  2022-08-02       Impact factor: 2.738

4.  Tumor Hypoxia Heterogeneity Affects Radiotherapy: Inverse-Percolation Shell-Model Monte Carlo Simulations.

Authors:  Argyris Dimou; Panos Argyrakis; Raoul Kopelman
Journal:  Entropy (Basel)       Date:  2022-01-05       Impact factor: 2.524

Review 5.  Recent Advances in Strategies for Addressing Hypoxia in Tumor Photodynamic Therapy.

Authors:  Liang Hong; Jiangmin Li; Yali Luo; Tao Guo; Chenshuang Zhang; Sha Ou; Yaohang Long; Zuquan Hu
Journal:  Biomolecules       Date:  2022-01-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.